Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIORA THERAPEUTICS, INC. (PROG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 69.8% | 71.9% |
| Gross profit | 100.0% | 100.0% | 30.2% | 28.1% |
| Sales and marketing | 381.6% | 3672.2% | 40.9% | 39.2% |
| Research and development | | | 44.0% | 38.1% |
| General and administrative | | | 42.6% | 40.0% |
| EBITDA | -9387.0% | -102632.1% | -94.1% | -86.3% |
| Depreciation | 115.2% | 887.7% | 3.2% | 4.7% |
| EBIT | -9502.2% | -103519.8% | -97.3% | -89.3% |
| Pre-tax income | -14325.6% | -88035.8% | -103.3% | -96.8% |
| Income taxes | -9.5% | -23167.9% | -0.5% | 4.1% |
| Net income | -19840.6% | -118844.4% | -158.9% | -0.1% |
|